Indeed, MiR-664b-5p inhibited tumour growth compared with the control in tumour xenograft models, and CCNE2 expression was also inversely correlated with miR-664b-5p expression in 90 TNBC patient samples [93]. The gene discussed is CCNE2; the disease is neoplasm.